Roivant Sciences (ROIV) Intangibles (2022 - 2024)
Roivant Sciences (ROIV) posted Intangibles of $136.0 million for Q2 2024, down 1.33% on a QoQ basis from $137.8 million in Q1 2024, and down 6.22% year-over-year from $145.0 million in Q3 2023.
Roivant Sciences (ROIV) Intangibles (2022 - 2024) Analysis & Trends
Roivant Sciences' Intangibles history runs 3 years deep, the most recent figure standing at $136.0 million for Q2 2024.
- Quarterly Intangibles fell 6.22% year-over-year to $136.0 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $136.0 million (down 6.22% YoY) and the FY2024 annual result came in at $137.8 million, down 9.69% from the prior year.
- Intangibles was $136.0 million for Q2 2024 at Roivant Sciences, down from $137.8 million in the prior quarter.
- Across five years, Intangibles topped out at $166.5 million in Q4 2023 and bottomed at $136.0 million in Q2 2024.
- A 3-year average of $145.9 million and a median of $145.0 million in 2023 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2023 — Intangibles increased 13.94% — and 2024, when it slipped 9.69%.
- Roivant Sciences' Intangibles stood at $146.1 million in 2022, then grew by 13.94% to $166.5 million in 2023, then slipped by 18.3% to $136.0 million in 2024.
- Business Quant data shows ROIV's Intangibles at $136.0 million in Q2 2024, $137.8 million in Q1 2024, and $166.5 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 11,640.44 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 61.68 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.92 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 55.80 Mn |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 136.01 Mn |
| Mar 31, 2024 | 137.84 Mn |
| Dec 31, 2023 | 166.47 Mn |
| Sep 30, 2023 | 140.62 Mn |
| Jun 30, 2023 | 145.04 Mn |
| Mar 31, 2023 | 152.63 Mn |
| Dec 31, 2022 | 146.11 Mn |
| Sep 30, 2022 | 143.21 Mn |
| Jun 30, 2022 | 145.43 Mn |